Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.50
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 1.00 (5.714%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix and partner Agropur launch 'SlimBiome' in North America

Fri, 31st Jan 2020 08:57

(Sharecast News) - Life sciences company OptiBiotix Health and its partner Agropur announced the launch of 'SlimBiome' in the North American market on Friday.
The AIM-traded firm said the launch was following its granting of an exclusive licence to Agropur in June, to manufacture, supply and distribute its SlimBiome weight management technology in the United States, Canada and Mexico.

It described Agropur as a wholly-owned subsidiary of Agropur Cooperative, which is a North American dairy industry "leader" founded in 1938.

"We are proud of our agreement and partnership with OptiBiotix and the exclusive opportunity to bring SlimBiome to the North American food and nutrition industries," said Mike Homewood, vice-president of Agropur Custom Solutions.

"This ingredient solution for weight management fits into Agropur's goal to provide innovative, forward-thinking products to our customers."

Dr Fred Narbel, managing director of OptiBiotix's prebiotics division, added that the company was "very pleased" with the progress Agropur had made since the announcement of the partnership at the end of June.

"Over a rather short period of time, Agropur has qualified its manufacturing process and is now able to produce SlimBiome in the US and supply the ingredient to North American business-to-business customers.

"This is a key strategic step In OptiBiotix's commercial development as it grants the company access to the US weight management market which was estimated to be worth $72bn in 2019."

At 1541 GMT, shares in OptiBiotix Health were up 1.27% at 62.28p.
More News
10 Aug 2021 11:24

OptiBiotix extends deal with Seed Health to other territories

(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its wholly-owned subsidiary ProBiotix Health has extended the territories of its original agreement with Seed Health, for the production, promotion, marketing and commercialisation of products containing 'LPLDL'.

Read more
5 Aug 2021 18:07

IN BRIEF: OptiBiotix Health confident in annual outlook on sales rise

IN BRIEF: OptiBiotix Health confident in annual outlook on sales rise

Read more
5 Aug 2021 13:43

OptiBiotix revenues see healthy rise in first half

(Sharecast News) - Obesity, cardiovascular and diabetes-focussed life sciences company OptiBiotix Health reported first-half total invoiced sales of 'LPLDL' and 'SlimBiome' as ingredient or final product of £1.074m in an update on Thursday, representing a year-on-year increase of 44.3% and ahead of its expectations for the period.

Read more
5 Aug 2021 10:44

AIM WINNERS & LOSERS: Mkango rises on deal to wholly own Songwe Hill

AIM WINNERS & LOSERS: Mkango rises on deal to wholly own Songwe Hill

Read more
6 Jul 2021 11:30

IN BRIEF: OptiBiotix continues Asian expansion with Inscobee deal

IN BRIEF: OptiBiotix continues Asian expansion with Inscobee deal

Read more
2 Jul 2021 15:52

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
17 Jun 2021 13:21

TRADING UPDATES: Anpario performance improves; Sumo outlook confident

TRADING UPDATES: Anpario performance improves; Sumo outlook confident

Read more
17 Jun 2021 12:13

OptiBiotix operating losses narrow as revenue surges

(Sharecast News) - Life sciences company OptiBiotix Health reported a 104% improvement in its full-year revenue on Thursday, to £1.52m.

Read more
21 Apr 2021 14:44

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

Read more
16 Apr 2021 15:17

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

Read more
23 Mar 2021 15:04

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

Read more
23 Mar 2021 08:06

Optibiotix names René Kamminga as CEO of subsidiary

(Sharecast News) - Biotechnology company Optibiotix Health named René Kamminga as chief executive officer of its OptiBiotix Ltd subsidiary on Tuesday, subject to completion of normal regulatory due diligence.

Read more
17 Mar 2021 15:50

OptiBiotix expands product ranges, sees positive drug trial results

OptiBiotix expands product ranges, sees positive drug trial results

Read more
18 Feb 2021 11:13

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

Read more
2 Feb 2021 14:38

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.